These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 21122648)

  • 1. Cholesterol crystals piercing the arterial plaque and intima trigger local and systemic inflammation.
    Abela GS
    J Clin Lipidol; 2010; 4(3):156-64. PubMed ID: 21122648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of statins on cholesterol crystallization and atherosclerotic plaque stabilization.
    Abela GS; Vedre A; Janoudi A; Huang R; Durga S; Tamhane U
    Am J Cardiol; 2011 Jun; 107(12):1710-7. PubMed ID: 21507364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting cholesterol crystal-induced inflammation for the secondary prevention of cardiovascular disease.
    Nidorf SM; Eikelboom JW; Thompson PL
    J Cardiovasc Pharmacol Ther; 2014 Jan; 19(1):45-52. PubMed ID: 24038016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From pathophysiology to targeted therapy for atherothrombosis: a role for the combination of statin and aspirin in secondary prevention.
    Chapman MJ
    Pharmacol Ther; 2007 Jan; 113(1):184-96. PubMed ID: 17070923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plaque Rupture and Thrombosis: the Value of the Atherosclerotic Rabbit Model in Defining the Mechanism.
    Abela OG; Ahsan CH; Alreefi F; Salehi N; Baig I; Janoudi A; Abela GS
    Curr Atheroscler Rep; 2016 Jun; 18(6):29. PubMed ID: 27091328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cholesterol crystals on plaques and intima in arteries of patients with acute coronary and cerebrovascular syndromes.
    Abela GS; Aziz K; Vedre A; Pathak DR; Talbott JD; Dejong J
    Am J Cardiol; 2009 Apr; 103(7):959-68. PubMed ID: 19327423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin E1 dose-dependently promotes stability of atherosclerotic plaque in a rabbit model.
    Bai W; Zheng X; Zhou L; Li H
    Can J Physiol Pharmacol; 2012 Feb; 90(2):131-9. PubMed ID: 22309388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines, macrophage lipid metabolism and foam cells: implications for cardiovascular disease therapy.
    McLaren JE; Michael DR; Ashlin TG; Ramji DP
    Prog Lipid Res; 2011 Oct; 50(4):331-47. PubMed ID: 21601592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of the WHHL rabbit, an animal model of familial hypercholesterolemia, to elucidation of the anti-atherosclerotic effects of statins.
    Shiomi M; Koike T; Ito T
    Atherosclerosis; 2013 Nov; 231(1):39-47. PubMed ID: 24125408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythrocyte membrane cholesterol and lipid core growth in a rabbit model of atherosclerosis: modulatory effects of rosuvastatin.
    Tziakas D; Chalikias G; Kapelouzou A; Tentes I; Schäfer K; Karayannakos P; Kostakis A; Boudoulas H; Konstantinides S
    Int J Cardiol; 2013 Dec; 170(2):173-81. PubMed ID: 24215985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraplaque hemorrhage and progression of coronary atheroma.
    Kolodgie FD; Gold HK; Burke AP; Fowler DR; Kruth HS; Weber DK; Farb A; Guerrero LJ; Hayase M; Kutys R; Narula J; Finn AV; Virmani R
    N Engl J Med; 2003 Dec; 349(24):2316-25. PubMed ID: 14668457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of statins on high-risk atherosclerotic plaque associated with low endothelial shear stress.
    Takahashi S; Papafaklis MI; Sakamoto S; Antoniadis AP; Coskun AU; Feldman CL; Stone PH
    Curr Opin Lipidol; 2011 Oct; 22(5):358-64. PubMed ID: 21841484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [C-reactive protein in coronary plaques -- prevalence with acute coronary syndrome].
    Andrié R; Maylahn M; Braun P; Lüderitz B; Bauriedel G
    Z Kardiol; 2002 Nov; 91(11):913-20. PubMed ID: 12442194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parallel cholesterol crystals: a sign of impending plaque rupture?
    Frink RJ
    J Invasive Cardiol; 2010 Sep; 22(9):406-11. PubMed ID: 20814046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of neovascularization and intraplaque haemorrhage to atherosclerotic plaque progression and instability.
    Chistiakov DA; Orekhov AN; Bobryshev YV
    Acta Physiol (Oxf); 2015 Mar; 213(3):539-53. PubMed ID: 25515699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast cells: multipotent local effector cells in atherothrombosis.
    Kovanen PT
    Immunol Rev; 2007 Jun; 217():105-22. PubMed ID: 17498055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability.
    Erbel C; Dengler TJ; Wangler S; Lasitschka F; Bea F; Wambsganss N; Hakimi M; Böckler D; Katus HA; Gleissner CA
    Basic Res Cardiol; 2011 Jan; 106(1):125-34. PubMed ID: 21116822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The promise of statins].
    Capurso A
    Ital Heart J Suppl; 2001 Mar; 2(3):224-9. PubMed ID: 11307780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishing an animal model of unstable atherosclerotic plaques.
    Chen WQ; Zhang Y; Zhang M; Ji XP; Yin Y; Zhu YF
    Chin Med J (Engl); 2004 Sep; 117(9):1293-8. PubMed ID: 15377416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol crystals cause mechanical damage to biological membranes: a proposed mechanism of plaque rupture and erosion leading to arterial thrombosis.
    Abela GS; Aziz K
    Clin Cardiol; 2005 Sep; 28(9):413-20. PubMed ID: 16250264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.